Skip to main content
. 2023 Feb 14;36(2):ivad037. doi: 10.1093/icvts/ivad037

Table 1:

Patient characteristics

Variables Total (n = 162) Lobectomy (n = 81) Segmentectomy (n = 81) P-Value
Sex (female), n (%) 79 (48.7) 39 (48.1) 40 (49.3) 0.875
Age (years), median (IQR)] 69 (63–74) 68 (60–73) 71 (65–76) 0.037
BMI (kg/m2), mean ± SD 25.3 ± 4.3 25.2 ± 4.3 25.9 ± 4.3 0.814
Comorbidities, n (%)
 Cardiopathy 46 (28.4) 20 (24.7) 26 (32) 0.297
 High blood pressure 86 (53) 43 (53) 43 (53) 1
 Atrial fibrillation 18 (11) 9 (11) 9 (11) 1
 Tobacco 132 (81.4) 63 (77.7) 69 (85) 0.228
 Diabetes 23 (14.1) 9 (11) 14 (17.2) 0.264
 Kidney failure 16 (9.8) 7 (8.6) 9 (11) 0.599
 Previous cancer 65 (40.1) 26 (32) 39 (48.1) 0.038
Preoperative pulmonary function, mean ± SD
 FEV1 (%) 86.03 ± 21.6 88.9 ± 21.1 86.1 ± 21.6 0.085
 DLCO (%) 73.4 ± 22.4 75.8 ± 22.6 71.1 ± 22.3 0.194
ASA score 2.52 ± 0.54 2.53 ± 0.54 2.52 ± 0.54 0.329
Histology, n (%)
 Adenocarcinoma 125 (77.1) 60 (74) 65 (80) 0.351a
 Squamous cell carcinoma 35 (21.6) 19 (23.4) 16 (19.8)
 Large cell tumour 2 (1) 2 (2) 0
Size (mm), mean ± SD 24.3 ± 3.1 25.1 ± 3.1 23.6 ± 3.1 0.001
 21–25, n (%) 114 (70.3) 46 (56.7) 68 (83.9) <0.001a
 25–30, n (%) 48 (29.7) 35 (43.3) 13 (16)
Localization, n (%)
 Right upper lobe 57 (35.2) 33 (40.7) 24 (29.6) 0.186a
 Right lower lobe 27 (16.7) 16 (19.8) 11 (13.6)
 Left upper lobe 52 (32.1) 21 (25.9) 31 (38.3)
 Left lower lobe 26 (16) 11 (13.6) 15 (18.5)
Dissected lymph nodes (n), median (IQR) 12 (7–19) 14 (9–23) 10 (6–15) <0.001
Operative time (min), median (IQR) 130 (103–157) 131 (105–162) 127 (100–155) 0.432
Adjuvant chemotherapy, n (%) 15 (9.2) 10 (12) 5 (6.1) 0.183
a

Fisher’s exact test.

ASA: American Society of Anaesthesiologists; BMI: body mass index; DLCO: diffusing capacity of the lung for carbon monoxide; FEV1: forced expiratory volume in 1 s; IQR: interquartile range; SD: standard deviation.